Gene transfer to the liver.
作者信息
Glaser V
出版信息
Mol Med Today. 1996 Feb;2(2):47. doi: 10.1016/1357-4310(96)88725-9.
PMID:8796851
Abstract
摘要
相似文献
1
Gene transfer to the liver.
Mol Med Today. 1996 Feb;2(2):47. doi: 10.1016/1357-4310(96)88725-9.
2
Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.
J Inherit Metab Dis. 1998;21 Suppl 1:119-37. doi: 10.1023/a:1005369926784.
3
Gene therapy death prompts review of adenovirus vector.
Science. 1999 Dec 17;286(5448):2244-5. doi: 10.1126/science.286.5448.2244.
4
A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.
Hum Gene Ther. 2002 Jan 1;13(1):163-75. doi: 10.1089/10430340152712719.
5
Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
Hum Gene Ther. 1996 May 1;7(7):821-30. doi: 10.1089/hum.1996.7.7-821.
6
[Gene therapy for ornithine transcarbamylase (OTC) deficient mice].
Tanpakushitsu Kakusan Koso. 1995 Dec;40(17):2674-8.
7
[Gene therapy for ornithine transcarbamylase deficiency].
Tanpakushitsu Kakusan Koso. 1995 Dec;40(17):2759-64.
8
Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector.
Hum Gene Ther. 1990 Fall;1(3):241-56. doi: 10.1089/hum.1990.1.3-241.
9
Fetal somatic gene therapy.
Mol Hum Reprod. 1996 Sep;2(9):633-41. doi: 10.1093/molehr/2.9.633.
10
Virus treatment questioned after gene therapy death.
Nature. 1999 Oct 7;401(6753):517-8. doi: 10.1038/43977.
Zotero 插件